"The
Report PharmaPoint: Prophylactic Human Papillomavirus Vaccines -
Canada Drug Forecast and Market Analysis to 2022 provides information
on pricing, market analysis, shares, forecast, and company profiles
for key industry participants. - MarketResearchReports.biz"
The first prophylactic vaccine
for immunization against human papillomavirus (HPV) became available
in 2006. The Gobal
HPV Vaccines Market is
now well established, yet vaccine coverage rates amongst the
traditional target population of adolescent girls remain persistently
low. Initially HPV vaccines were developed and marketed solely to
protect against cervical cancer. In recent years the role of HPV in
other cancers has been increasingly recognized which has facilitated
a shift towards vaccinating a wider population, most significant has
been the inclusion of males in routine vaccine recommendations in
some countries. The current HPV vaccines market is dominated by one
major player, Mercks Gardasil, with GlaxoSmithKlines (GSKs) HPV
vaccine Cervarix providing the only competition. The introduction of
Mercks nine-valent vaccine (V503) is set to change the future
landscape of the HPV vaccines sector.
The anticipated addition of
boys to routine HPV vaccine recommendations by different Canadian
provinces is expected to serve as a significant driver to growth
within the HPV vaccines market in Canada over the forecast period. In
addition, from primary research insight, GlobalData projects Mercks
nine-valent vaccine V503 to be widely adopted in the country. This
will also significantly enhance the size of the HPV vaccines sector
in Canada.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/210574
Scope
-
Overview of Prophylactic Human Papillomavirus Vaccines including
epidemiology, etiology, symptoms, diagnosis, pathology and treatment
guidelines as well as an overview on the competitive landscape.
-
Detailed information on the key drugs in the Canada including product
description, safety and efficacy profiles as well as a SWOT analysis.
-
Sales forecast for the top drugs in the Canada from 2012-2022.
-
Analysis of the impact of key events as well the drivers and
restraints affecting the Canada Prophylactic Human Papillomavirus
Vaccines disease market.
Reasons
to buy
-
Understand and capitalize by identifying products that are most
likely to ensure a robust return
-
Stay ahead of the competition by understanding the changing
competitive landscape for Prophylactic Human Papillomavirus Vaccines
-
Effectively plan your M&A and partnership strategies by
identifying drugs with the most promising sales potential
-
Make more informed business decisions from insightful and in-depth
analysis of drug performance
-
Obtain sales forecast for drugs from 2012-2022 in the Canada
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
of Contents
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
2.3 Upcoming Related Reports 11
3 Disease Overview 12
3.1 Etiology and
Pathophysiology 12
3.1.1 Etiology 12
3.1.2 Pathophysiology 13
3.2 Symptoms 15
4 Vaccination Recommendations
and Coverage Rates 17
4.1 Canada 17
4.1.1 Vaccination
Recommendations and Policies 17
4.1.2 Vaccination Coverage 18
4.1.3 Clinical Practice 20
5 Competitive Assessment 22
5.1 Overview 22
5.2 Strategic Competitor
Assessment 22
5.3 Product Profiles 24
5.3.1 Gardasil 24
5.3.2 Cervarix 30
6 Unmet Need and Opportunity 35
6.1 Overview 35
6.2 Protection against Multiple
HPV Types 36
6.2.1 Unmet Need 36
6.2.2 Gap Analysis 37
6.2.3 Opportunity 38
6.3 Vaccine Coverage Rates 38
6.3.1 Unmet Need 38
6.3.2 Gap Analysis 39
6.3.3 Opportunity 39
6.4 Perception of Vaccine
Safety 40
6.4.1 Unmet Need 40
6.4.2 Gap Analysis 41
6.4.3 Opportunity 41
6.5 Awareness of HPV
Vaccination 42
6.5.1 Unmet Need 42
6.5.2 Gap Analysis 42
6.5.3 Opportunity 43
6.6 Affordability of HPV
Vaccines 43
6.6.1 Unmet Need 43
6.6.2 Gap Analysis 44
6.6.3 Opportunity 44
6.7 Coverage of HPV Types
Prevalent in Certain Populations 45
6.7.1 Unmet Need 45
6.7.2 Gap Analysis 46
6.7.3 Opportunity 46
6.8 Vaccine Compliance Rates 46
6.8.1 Unmet Need 46
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment